Lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal] — RxCUI 849049
RxNorm drug concept · Semantic branded drug
RxCUI 849049
Semantic branded drug · SBD
● Current RxNorm concept 16 FDA products
18 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI849049
Official nameLamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLamictal ODT 100 MG Disintegrating Oral Tablet
FDA products mapped16
Package NDCs mapped18
Reported Medicaid activity (SDUD)23,420 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lamotrigine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats epilepsy, helping control certain seizure types. Some forms, like tablets, chewables and orally disintegrating tablets, are also used to delay mood episodes in bipolar I...
- Lamotrigine can cause serious, even life-threatening skin reactions, mostly in the first 2 to 8 weeks. We can't tell which rashes are dangerous, so call your doctor right away abou...
- Take it by mouth exactly as prescribed, increasing slowly as planned. Skipping ahead raises rash risk. Extended-release tablets are once daily and must be swallowed whole. Food doe...
- Please don't stop on your own. Stopping suddenly can trigger withdrawal seizures. Your doctor will taper you off over at least 2 weeks.
🕸️ Concept Web — How Lamotrigine 100 MG Disintegrating Oral Tablet [L... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]
RxCUI 849049 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Lamotrigine
28439IN
-
Lamotrigine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lamictal
196502BN
-
Lamictal
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lamotrigine Disintegrating Oral Tablet
372566SCDF -
Lamotrigine Disintegrating Oral Product
1295036SCDG -
Lamotrigine Oral Product
1162535SCDG -
Lamotrigine Pill
1162536SCDG -
Lamotrigine Disintegrating Oral Tablet [Lamictal]
849048SBDF -
Lamictal Disintegrating Oral Product
1296382SBDG -
Lamictal Oral Product
1174986SBDG -
Lamictal Pill
1174987SBDG - +4 more in this family
-
Lamotrigine Disintegrating Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lamotrigine 100 MG Disintegrating Oral Tablet
103968SCD -
Lamotrigine 100 MG
316129SCDC -
Lamotrigine 100 MG [Lamictal]
563872SBDC
-
Lamotrigine 100 MG Disintegrating Oral Tablet
-
Packs 4
Fixed collections of drugs packaged and sold together, like dose packs.
-
{14 (lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]) / 42 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Green Titration Kit (for Patients Taking Enzyme-Inducing Drugs and Not Taking Valproate)]
851753BPCK -
{7 (lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]) / 14 (lamotrigine 25 MG Disintegrating Oral Tablet [Lamictal]) / 14 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Orange Patient Titration Kit (For Patients Not Taking Enzyme-Inducing Drugs or Valproate)]
851751BPCK -
{14 (lamotrigine 100 MG Disintegrating Oral Tablet) / 42 (lamotrigine 50 MG Disintegrating Oral Tablet) } Pack
851752GPCK -
{7 (lamotrigine 100 MG Disintegrating Oral Tablet) / 14 (lamotrigine 25 MG Disintegrating Oral Tablet) / 14 (lamotrigine 50 MG Disintegrating Oral Tablet) } Pack
851750GPCK
-
{14 (lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]) / 42 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Green Titration Kit (for Patients Taking Enzyme-Inducing Drugs and Not Taking Valproate)]
Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lamotrigine 100 MG Disintegrating Oral Tablet
SCD · 103968 -
{14 (lamotrigine 100 MG Disintegrating Oral Tablet) / 42 (lamotrigine 50 MG Disintegrating Oral Tablet) } Pack
GPCK · 851752 -
{7 (lamotrigine 100 MG Disintegrating Oral Tablet) / 14 (lamotrigine 25 MG Disintegrating Oral Tablet) / 14 (lamotrigine 50 MG Disintegrating Oral Tablet) } Pack
GPCK · 851750 -
Lamotrigine 100 MG
SCDC · 316129 -
Lamotrigine Disintegrating Oral Tablet
SCDF · 372566 -
Lamotrigine Disintegrating Oral Product
SCDG · 1295036 -
Lamotrigine Oral Product
SCDG · 1162535 -
Lamotrigine Pill
SCDG · 1162536
Brand-Name Concepts
-
{14 (lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]) / 42 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Green Titration Kit (for Patients Taking Enzyme-Inducing Drugs and Not Taking Valproate)]
BPCK · 851753 -
{7 (lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal]) / 14 (lamotrigine 25 MG Disintegrating Oral Tablet [Lamictal]) / 14 (lamotrigine 50 MG Disintegrating Oral Tablet [Lamictal]) } Pack [Lamictal ODT Orange Patient Titration Kit (For Patients Not Taking Enzyme-Inducing Drugs or Valproate)]
BPCK · 851751 -
Lamotrigine 100 MG [Lamictal]
SBDC · 563872 -
Lamotrigine Disintegrating Oral Tablet [Lamictal]
SBDF · 849048 -
Lamictal Disintegrating Oral Product
SBDG · 1296382 -
Lamictal Oral Product
SBDG · 1174986 -
Lamictal Pill
SBDG · 1174987 -
Lamictal
BN · 196502
📦 FDA Products & Package NDCs
16 products · 18 package NDCs
18 package NDCs map to RxCUI 849049 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00173-0526-00 | 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0526-00) | LAMICTAL | GlaxoSmithKline LLC | 1998-09-04 |
| 00173-0527-00 | 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0527-00) | LAMICTAL | GlaxoSmithKline LLC | 1998-09-03 |
| 00173-0594-02 | 1 BLISTER PACK in 1 PACKAGE, COMBINATION (0173-0594-02) / 1... | LAMICTAL | GlaxoSmithKline LLC | 2003-09-29 |
| 00173-0633-02 | 100 TABLET in 1 BOTTLE (0173-0633-02) | LAMICTAL | GlaxoSmithKline LLC | 1996-08-15 |
| 00173-0633-10 | 35 TABLET in 1 DOSE PACK (0173-0633-10) | LAMICTAL | GlaxoSmithKline LLC | 1996-08-15 |
| 00173-0642-55 | 100 TABLET in 1 BOTTLE (0173-0642-55) | LAMICTAL | GlaxoSmithKline LLC | 1995-01-17 |
| 00173-0643-60 | 60 TABLET in 1 BOTTLE (0173-0643-60) | LAMICTAL | GlaxoSmithKline LLC | 1995-01-17 |
| 00173-0644-60 | 60 TABLET in 1 BOTTLE (0173-0644-60) | LAMICTAL | GlaxoSmithKline LLC | 1995-01-18 |
| 00173-0699-00 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0699-00) | LAMICTAL | GlaxoSmithKline LLC | 2000-10-12 |
| 00173-0699-02 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0699-02) | LAMICTAL | GlaxoSmithKline LLC | 2000-10-12 |
| 00173-0772-02 | 1 DOSE PACK in 1 CARTON (0173-0772-02) / 30 TABLET, ORALLY... | LAMICTAL ODT | GlaxoSmithKline LLC | 2009-06-05 |
| 00173-0774-02 | 1 DOSE PACK in 1 CARTON (0173-0774-02) / 30 TABLET, ORALLY... | LAMICTAL ODT | GlaxoSmithKline LLC | 2009-06-05 |
| 00173-0776-02 | 1 DOSE PACK in 1 CARTON (0173-0776-02) / 30 TABLET, ORALLY... | LAMICTAL ODT | GlaxoSmithKline LLC | 2009-06-05 |
| 00173-0777-02 | 1 DOSE PACK in 1 CARTON (0173-0777-02) / 30 TABLET, ORALLY... | LAMICTAL ODT | GlaxoSmithKline LLC | 2009-06-05 |
| 00173-0778-00 | 1 BLISTER PACK in 1 PACKAGE, COMBINATION (0173-0778-00) / 1... | LAMICTAL ODT | GlaxoSmithKline LLC | 2009-06-05 |
| 00173-0779-00 | 1 BLISTER PACK in 1 PACKAGE, COMBINATION (0173-0779-00) / 1... | LAMICTAL ODT | GlaxoSmithKline LLC | 2009-06-05 |
| 00173-0780-00 | 1 BLISTER PACK in 1 PACKAGE, COMBINATION (0173-0780-00) / 1... | LAMICTAL ODT | GlaxoSmithKline LLC | 2009-06-05 |
| 00173-0817-28 | 1 BLISTER PACK in 1 PACKAGE, COMBINATION (0173-0817-28) / 1... | LAMICTAL | GlaxoSmithKline LLC | 2003-09-29 |
Observed labelers:
GlaxoSmithKline LLC (18)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.